Archives

by in
Entry Author Date Location
The Missing Ingredient in Today’s Biotech: Guts 07/11/11 National
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News 04/28/11 Seattle
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO 04/27/11 Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech 11/09/10 Seattle
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster 10/26/10 Seattle
What Will Happen to ZymoGenetics’ Landmark Headquarters when Bristol Calls the Shots? 09/13/10 Seattle
Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three 07/27/10 Seattle
Immune Design Nabs $32M for Targeted Vaccines 07/26/10 Seattle
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News 03/18/10 Seattle
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Bezos Family Gives $10M to Hutch, Bruce Carter Back in the Saddle, Dendreon Deadline Set, & More Seattle-Area Life Sciences News 11/25/09 Seattle
So Much For Gardening: Bruce Carter Joins Vaccine Startup Immune Design To Raise Cash 11/23/09 Seattle
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO 09/18/09 Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety 08/20/09 Seattle
Johnson & Johnson, TB Alliance Form Partnership to Push New TB Drug Through Clinic 06/17/09 Seattle
Life Sciences on a Budget: Startups Make Pitch for Angel Dollars at First Zino Society Forum 02/25/09 Seattle
Hey, Don’t Forget the Puget Sound Life Sciences Universe! 02/09/09 Seattle
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex 01/05/09 Seattle
Seattle’s Top 10 Innovation Stories of the Half-Year (and Others We Just Plain Liked) 12/31/08 Seattle
Washington’s Life Sciences Ambassador, Jack Faris, Exits the Stage 12/29/08 Seattle
3Tier Group Gets $10M, Socialmedian Sold for $7.5M, Gates Gives $7M to IDRI, & More Seattle-Area Deals News 12/23/08 Seattle
Amgen Tries to “Personalize” Drug, VLST Snags Deal, Tobacco Money Backs Research, & More Seattle-Area Life Sciences News 12/18/08 Seattle
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity 12/17/08 Seattle
Luck, Curiosity, Naivete: The Essential Ingredients of Innovation 12/16/08 Seattle
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News 12/04/08 Seattle
ZymoGenetics CEO Bruce Carter Retires, Promotes Doug Williams, Says Sad Goodbyes to Biotech “Family” 11/21/08 Seattle
WBBA Hires Chris Rivera As President, Replacing Retiring Jack Faris 11/19/08 Seattle
ZymoGenetics “Sleeper” for Hepatitis C Aims to Wipe Out Side Effects of Anti-Viral Therapy 09/30/08 Seattle
ZymoGenetics Drug Getting Off to Slow Start in Marketplace 08/06/08 Seattle
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.